MASTER SERVICES AGREEMENTMaster Services Agreement • February 14th, 2014 • DanDrit Biotech USA, Inc. • Blank checks • England
This Master Services Agreement (the “Agreement”) is made and entered into on 11th October, 2011, (the “Effective Date”), by and between DanDrit Biotech A/S, a Danish corporation, with offices at Høffdingsvej 34, 2500 Valby, Denmark (hereinafter referred to as “Client”) and Aptiv Solutions (UK) Ltd, together with its Affiliates, with offices at Hemel One, Boundary Way, Hemel Hempstead, Hertfordshire, HP2 (hereinafter referred to as “Aptiv Solutions”), both hereinafter referred as a “Party” or collectively as the “Parties”.
AGREEMENT AND PLAN OF SHARE EXCHANGEShare Exchange Agreement • February 14th, 2014 • DanDrit Biotech USA, Inc. • Blank checks • Delaware
This AGREEMENT AND PLAN OF SHARE EXCHANGE (this “Agreement”) is entered into as of this 12th day of February, 2014 by and among Putnam Hills Corp., a Delaware corporation (“Putnam”), Dandrit BioTech A/S, a Danish company (“Dandrit”) and Niels Erik Nielsen (the “Shareholders’ Representative”), the representative of shareholders a majority of the issued and outstanding capital stock of Dandrit (collectively, the “Dandrit Consenting Shareholders” and together will all other holders of the outstanding capital stock of Dandrit, each a “Dandrit Shareholder”, and collectively, the “Dandrit Shareholders”). Each of the parties to this Agreement is individually referred to herein as a “Party” and collectively as the “Parties”.
DEBT INSTRUMENT was concluded on this day between Sune Olsen Holding ApS Jagtvej 169B, 3rd floor DK-2100 Copenhagen Ø Danish CVR No 25372727 of the first part (hereinafter referred to as the “Creditor”) and Dandrit Biotech A/S Symbion Sciencepark,...Debt Instrument • February 14th, 2014 • DanDrit Biotech USA, Inc. • Blank checks
Place: Copenhagen Ø Place: Copenhagen Ø Date: March 31, 2013 Date: March 31, 2013 As the Debtor: As the Creditor: /s/ Eric Leire, CEO, DanDrit Biotech A/S /s/ Sune Olsen, President, Sune Olsen Holding ApS
EARLY ACCESS AGREEMENTEarly Access Agreement • February 14th, 2014 • DanDrit Biotech USA, Inc. • Blank checks
This exclusive Early Access Agreement (“Agreement”) is made and entered into the 20th day of December 2013 (“Effective Date”) by and between
LOAN AGREEMENTLoan Agreement • February 14th, 2014 • DanDrit Biotech USA, Inc. • Blank checks
This CONSULTANCY AGREEMENT has today been made betweenConsultancy Agreement • February 14th, 2014 • DanDrit Biotech USA, Inc. • Blank checks
This Agreement has been drawn up in two copies which have been distributed to the Consultant and the Company, respectively.
Colla boration AgreementCollaboration Agreement • February 14th, 2014 • DanDrit Biotech USA, Inc. • Blank checks
The Company and NCC wish to collaborate regarding a clinical Named patient Use program conducted in Singapore at NCC with the dendritic cell vaccine MelCancerVac® belonging to the Company. The program is further defined in Appendix A hereto and shall hereinafter be referred to as the “NpU program”.
SHARE CANCELLATION AGREEMENTShare Cancellation Agreement • February 14th, 2014 • DanDrit Biotech USA, Inc. • Blank checks • Delaware
THIS SHARE CANCELLATION AGREEMENT (this “Agreement”) is made and entered into as of this 12th day of February, 2014, by and between Putnam Hills Corp., a Delaware corporation (the “Company”), and NLBDIT 2010 Services, LLC (the “Stockholder”). Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to them in the Exchange Agreement (as hereinafter defined).
Alexei Kirkin Strandboulevarden 61, 2nd floor to the left DK-2100 Copenhagen øIntellectual Property Assignment Agreement • February 14th, 2014 • DanDrit Biotech USA, Inc. • Blank checks
has, in connection with the Employment contract accepted on 31 August 2001, concluded an agreement to the effect that all intellectual property rights. according to the letter of 29 March 2001 from the Danish Cancer Society have been assigned to DanDrit Biotech A/S.
Consulting AgreementConsulting Agreement • February 14th, 2014 • DanDrit Biotech USA, Inc. • Blank checks • New York
This Consulting Agreement (the “Agreement”) is made as of this 11th day of February, 2014, by and between Putnam Hills Corp. (the “Company”) and Paseco ApS (the “Consultant”). In consideration of the mutual promises contained herein and other good and valuable consideration, the receipt and sufficiency of which is acknowledged, the parties agree as follows:
E M P L O Y M E N T A G R E E M E N T has today been made betweenEmployment Agreement • February 14th, 2014 • DanDrit Biotech USA, Inc. • Blank checks
